ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1658

Title: Inflammatory Arthritis Across the Age-Spectrum: Single-Cell Profiling of the Inflamed Synovium in Children with Juvenile Idiopathic Arthritis

Chrissy Bolton1, Christopher Mahony2, Charlotte Smith2, Vicky Alexiou3, Huong Nguyen3, Patricia Reis-Nisa2, Søren Lomholt4, Annie Hackland2, Sugrah Sultan5, Klaudia Kupiec3, Sunit Davda6, Charlene Foley6, Calliope Dendrou1, Elizabeth C Rosser7, Accelerating Medicines Partnership Program RA SLE Network8, Anna Helena Jonsson9, Fan Zhang10, Michael Brenner11, Soumya Raychaudhuri9, Christopher Buckley1, Manigandan Thyagarajan5, Zishan Shiekh5, Sandrine Compeyrot-Lacassagne6, Samantha Chippington6, Mark Coles1, Eslam Al-Abadi5, Andrew Filer2, Tissue Research in Childhood Onset Inflammatory Arthritis (TRICIA) Consortium12, Lucy R Wedderburn3 and Adam Croft2, 1University of Oxford, Oxford, United Kingdom, 2University of Birmingham, Birmingham, United Kingdom, 3UCL Great Ormond Street Institute of Child Health, London, United Kingdom, 4Aarhus University, Aarhus, Denmark, 5Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom, 6Great Ormond Street Hospital, London, United Kingdom, 7University College London, London, United Kingdom, 8Cedars-Sinai Medical Center, Los Angeles, CA, 9Brigham and Women's Hospital, Boston, MA, 10University of Colorado, Aurora, CO, 11Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 12MRC, Birmingham, United Kingdom

Meeting: ACR Convergence 2023

Keywords: Bioinformatics, interferon, Juvenile idiopathic arthritis, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: Pediatric Rheumatology – Basic Science

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: Understanding the unique and shared pathogenic processes between childhood-onset and adult-onset inflammatory arthritides is needed to guide more effective drug development and their application to different age groups. Difficulties in accessing samples from the inflamed tissue site in children has limited our understanding of disease mechanisms that operate locally in the joint. As part of the Tissue Research in Childhood Onset Inflammatory Arthritis (TRICIA) Consortium, we have established the first single cell multi-omic atlas of the inflamed joint in Juvenile Idiopathic Arthritis (JIA).

Methods: Ultrasound-guided needle biopsies of synovial tissue, with matched synovial fluid and peripheral blood mononuclear cell samples were obtained from n=12 pediatric patients with JIA, who were naïve to disease-modifying anti-rheumatic drugs. Multimodal single-cell characterisation of cells (n = 250, 816 cells, with scRNA-seq, VDJ-sequencing and TotalSeq surface assays) and multiplexed imaging of synovial tissue fragments were performed.

Results: Transcriptomic profiles of hematopoietic cells at a global level of clustering revealed that synovial tissue and synovial fluid were proportionally enriched in the same cellular subtypes (dendritic cell subsets, myeloid and memory CD8+ T cells) compared to blood ( > 0.58 log2 fold difference, FDR < 0.01, Fig 1). Core tissue-enriched populations identified in adult rheumatoid arthritis (Zhang et al., 2022, the AMP RA/SLE network) were also prominent in pediatric synovial tissue samples, including GZMK+ memory CD8+ T cells, CXCL13+ CD4+ T peripheral helper cells and NR4A+ germinal centre-like B cells. Evidence for a distinct immune environment of the synovial fluid cavity relative to synovial tissue included upregulation of interferon-response genes, greater proportions of dendritic cells (Fig 1), less diversity of αβ T cell receptors on CD8+ T cells (P = 0.02) and more hyperexpanded CD8+ T cell clones: 13.6% of total T cells in synovial fluid had the same clonotype in ≥ 20 cells, compared to 3.8% in synovial tissue (n = 8091 and 7039 cells respectively).

Conclusion: Our work implicates the synovial fluid cavity in disease pathogenesis, with synovial fluid providing a reservoir of free-flowing activated cells as barrier integrity breaks down. Despite distinct disease features and physiology, our analysis identifies shared cellular phenotypes within inflamed synovium between children and adults. This suggests that certain pathogenic mechanisms extend across the age-spectrum in inflammatory arthritis, enabling a more informed approach to clinical trials in children in the future.

References: Zhang, F. et al. (2022) ‘Cellular deconstruction of inflamed synovium defines diverse inflammatory phenotypes in rheumatoid arthritis’. bioRxiv, p. 2022.02.25.481990. Available at: https://doi.org/10.1101/2022.02.25.481990.

Supporting image 1

Comparative analysis highlights conserved proportions of hematopoietic cells between synovial tissue and fluid in children with Juvenile Idiopathic Arthritis
a) Integrated scRNA-seq global UMAP of major cellular clusters and their b) proportional difference between different specimen types, with bootstrap confidence intervals shown (10,000 permutations).


Disclosures: C. Bolton: None; C. Mahony: None; C. Smith: None; V. Alexiou: None; H. Nguyen: None; P. Reis-Nisa: None; S. Lomholt: None; A. Hackland: None; S. Sultan: None; K. Kupiec: None; S. Davda: None; C. Foley: None; C. Dendrou: None; E. Rosser: None; A. RA SLE Network: None; A. Jonsson: None; F. Zhang: None; M. Brenner: 4FO Ventures, 2, GlaxoSmithKlein(GSK), 2, Mestag Therapeutics, 2, 11, Third Rock Ventures, 2; S. Raychaudhuri: AbbVie, 6, Janssen, 1, Mestag, Inc, 2, 8, Pfizer, 1, Sanofi, 1, Sonoma, 1, 8; C. Buckley: Bristol-Myers Squibb(BMS), 5, Mestag, 11; M. Thyagarajan: None; Z. Shiekh: None; S. Compeyrot-Lacassagne: None; S. Chippington: None; M. Coles: None; E. Al-Abadi: None; A. Filer: Bristol-Myers Squibb(BMS), 5, GlaxoSmithKlein(GSK), 5, Janssen, 5, Nascient, 5, Sonoma Biotherapeutics, 2; T. Inflammatory Arthritis (TRICIA) Consortium: None; L. Wedderburn: AbbVie/Abbott, 5, GlaxoSmithKlein(GSK), 5, Pfizer, 1, SOBI, 5, UCB, 5; A. Croft: None.

To cite this abstract in AMA style:

Bolton C, Mahony C, Smith C, Alexiou V, Nguyen H, Reis-Nisa P, Lomholt S, Hackland A, Sultan S, Kupiec K, Davda S, Foley C, Dendrou C, Rosser E, RA SLE Network A, Jonsson A, Zhang F, Brenner M, Raychaudhuri S, Buckley C, Thyagarajan M, Shiekh Z, Compeyrot-Lacassagne S, Chippington S, Coles M, Al-Abadi E, Filer A, Inflammatory Arthritis (TRICIA) Consortium T, Wedderburn L, Croft A. Title: Inflammatory Arthritis Across the Age-Spectrum: Single-Cell Profiling of the Inflamed Synovium in Children with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/title-inflammatory-arthritis-across-the-age-spectrum-single-cell-profiling-of-the-inflamed-synovium-in-children-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/title-inflammatory-arthritis-across-the-age-spectrum-single-cell-profiling-of-the-inflamed-synovium-in-children-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology